| [1] |
Jochems D, van Wessem KJP, Houwert RM, et al. Outcome in patients with isolated moderate to severe traumatic brain injury[J]. Crit Care Res Pract, 2018, 2018: 3769418. DOI: 10.1155/2018/3769418.
|
| [2] |
Alali AS, Burton K, Fowler RA, et al. Economic evaluations in the diagnosis and management of traumatic brain injury: a systematic review and analysis of quality[J]. Value Health, 2015, 18(5): 721-734. DOI: 10.1016/j.jval.2015.04.012.
|
| [3] |
Taylor CA, Bell JM, Breiding MJ, et al. Traumatic brain injury-related emergency department visits, hospitalizations, and deaths - united states, 2007 and 2013[J]. MMWR Surveill Summ, 2017, 66(9): 1-16. DOI: 10.15585/mmwr.ss6609a1.
|
| [4] |
Folkerson LE, Sloan D, Cotton BA, et al. Predicting progressive hemorrhagic injury from isolated traumatic brain injury and coagulation[J]. Surgery, 2015, 158(3): 655-661. DOI: 10.1016/j.surg.2015.02.029.
|
| [5] |
Cepeda S, Gómez PA, Castaño-Leon AM, et al. Traumatic intracerebral hemorrhage: risk factors associated with progression[J]. J Neurotrauma, 2015, 32(16): 1246-1253. DOI: 10.1089/neu.2014.3808.
|
| [6] |
Oertel M, Kelly DF, McArthur D, et al. Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury[J]. J Neurosurg, 2002, 96(1): 109-116. DOI: 10.3171/jns.2002.96.1.0109.
|
| [7] |
Stein SC, Young GS, Talucci RC, et al. Delayed brain injury after head trauma: significance of coagulopathy[J]. Neurosurgery, 1992, 30(2): 160-165. DOI: 10.1227/00006123-199202000-00002.
|
| [8] |
White CL, Griffith S, Caron JL. Early progression of traumatic cerebral contusions: characterization and risk factors[J]. J Trauma, 2009, 67(3): 508-514; discussion 514-515. DOI: 10.1097/TA.0b013e3181b2519f.
|
| [9] |
Webb AJ, Brown CS, Naylor RM, et al. Thromboelastography is a marker for clinically significant progressive hemorrhagic injury in severe traumatic brain injury[J]. Neurocrit Care, 2021, 35(3): 738-746. DOI: 10.1007/s12028-021-01217-0.
|
| [10] |
Vedantam A, Yamal JM, Rubin ML, et al. Progressive hemorrhagic injury after severe traumatic brain injury: effect of hemoglobin transfusion thresholds[J]. J Neurosurg, 2016, 125(5): 1229-1234. DOI: 10.3171/2015.11.JNS151515.
|
| [11] |
Yuan Q, Sun YR, Wu X, et al. Coagulopathy in traumatic brain injury and its correlation with progressive hemorrhagic injury: a systematic review and meta-analysis[J]. J Neurotrauma, 2016, 33(14): 1279-1291. DOI: 10.1089/neu.2015.4205.
|
| [12] |
van Gent JAN, van Essen TA, Bos MHA, et al. Coagulopathy after hemorrhagic traumatic brain injury, an observational study of the incidence and prognosis[J]. Acta Neurochir (Wien), 2020, 162(2): 329-336. DOI: 10.1007/s00701-019-04111-z.
|
| [13] |
Tian Y, Salsbery B, Wang M, et al. Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury[J]. Blood, 2015, 125(13): 2151-2159. DOI: 10.1182/blood-2014-09-598805.
|
| [14] |
Liu J, Tian HL. Relationship between trauma-induced coagulopathy and progressive hemorrhagic injury in patients with traumatic brain injury[J]. Chin J Traumatol, 2016, 19(3): 172-175. DOI: 10.1016/j.cjtee.2016.01.011.
|
| [15] |
Díaz-Romero R, Avendaño P, Coloma G. Life-threatening paradoxical brain herniation rapidly reversed by emergency cranioplasty repair: a case report[J]. Acta Neurochir (Wien), 2015, 157(11): 2031-2032. DOI: 10.1007/s00701-015-2569-3.
|
| [16] |
Wan X, Fan T, Wang S, et al. Progressive hemorrhagic injury in patients with traumatic intracerebral hemorrhage: characteristics, risk factors and impact on management[J]. Acta Neurochir (Wien), 2017, 159(2): 227-235. DOI: 10.1007/s00701-016-3043-6.
|
| [17] |
Carnevale JA, Segar DJ, Powers AY, et al. Blossoming contusions: identifying factors contributing to the expansion of traumatic intracerebral hemorrhage[J]. J Neurosurg, 2018, 129(5): 1305-1316. DOI: 10.3171/2017.7.JNS17988.
|
| [18] |
Rehman L, Afzal A, Aziz HF, et al. Radiological parameters to predict hemorrhagic progression of traumatic contusional brain injury[J]. J Neurosci Rural Pract, 2019, 10(2): 212-217. DOI: 10.4103/jnrp.jnrp_335_18.
|
| [19] |
Allison RZ, Nakagawa K, Hayashi M, et al. Derivation of a predictive score for hemorrhagic progression of cerebral contusions in moderate and severe traumatic brain injury[J]. Neurocrit Care, 2017, 26(1): 80-86. DOI: 10.1007/s12028-016-0303-5.
|
| [20] |
Di G, Liu H, Jiang X, et al. Clinical predictors of progressive hemorrhagic injury in children with mild traumatic brain injury[J]. Front Neurol, 2017, 8: 560. DOI: 10.3389/fneur.2017.00560.
|
| [21] |
Kim WH, Lim DJ, Kim SH, et al. Is routine repeated head CT necessary for all pediatric traumatic brain injury?[J]. J Korean Neurosurg Soc, 2015, 58(2): 125-130. DOI: 10.3340/jkns.2015.58.2.125.
|
| [22] |
Picetti E, Rossi S, Abu-Zidan FM, et al. WSES consensus conference guidelines: monitoring and management of severe adult traumatic brain injury patients with polytrauma in the first 24 hours[J]. World J Emerg Surg, 2019, 14: 53. DOI: 10.1186/s13017-019-0270-1.
|
| [23] |
Martin G, Shah D, Elson N, et al. Relationship of coagulopathy and platelet dysfunction to transfusion needs after traumatic brain injury[J]. Neurocrit Care, 2018, 28(3): 330-337. DOI: 10.1007/s12028-017-0485-5.
|
| [24] |
Gratz J, Güting H, Thorn S, et al. Protocolised thromboelastometric-guided haemostatic management in patients with traumatic brain injury: a pilot study[J]. Anaesthesia, 2019, 74(7): 883-890. DOI: 10.1111/anae.14670.
|
| [25] |
Zhang J, He M, Song Y, et al. Prognostic role of D-dimer level upon admission in patients with traumatic brain injury[J]. Medicine (Baltimore), 2018, 97(31): e11774. DOI: 10.1097/MD.0000000000011774.
|
| [26] |
Zhao H, Cai X, Liu N, et al. Thromboelastography as a tool for monitoring blood coagulation dysfunction after adequate fluid resuscitation can predict poor outcomes in patients with septic shock[J]. J Chin Med Assoc, 2020, 83(7): 674-677. DOI: 10.1097/JCMA.0000000000000345.
|
| [27] |
Peng Q, Zhao J, Wang P, et al. Expressions of plasma cystatin C, D-dimer and hypersensitive C-reactive protein in patients with intracranial progressive hemorrhagic injury after craniocerebral injury, and their clinical significance[J]. Arq Neuropsiquiatr, 2019, 77(6): 381-386. DOI: 10.1590/0004-282X20190057.
|
| [28] |
Fujiwara G, Okada Y, Sakakibara T, et al. The association between D-dimer levels and long-term neurological outcomes of patients with traumatic brain injury: an analysis of a nationwide observational neurotrauma database in Japan[J]. Neurocrit Care, 2022, 36(2): 483-491. DOI: 10.1007/s12028-021-01329-7.
|
| [29] |
Karsy M, Kim R, Azab M, et al. Higher admission D-dimer values are associated with an increased risk of nonroutine discharge in neurosurgery patients[J]. Cureus, 2020, 12(7): e9425. DOI: 10.7759/cureus.9425.
|
| [30] |
Sheng J, Chen W, Zhuang D, et al. A clinical predictive nomogram for traumatic brain parenchyma hematoma progression[J]. Neurol Ther, 2022, 11(1): 185-203. DOI: 10.1007/s40120-021-00306-8.
|
| [31] |
Xu DX, Du WT, Li X, et al. D-dimer/fibrinogen ratio for the prediction of progressive hemorrhagic injury after traumatic brain injury[J]. Clin Chim Acta, 2020, 507: 143-148. DOI: 10.1016/j.cca.2020.04.022.
|
| [32] |
Joseph B, Aziz H, Zangbar B, et al. Acquired coagulopathy of traumatic brain injury defined by routine laboratory tests: which laboratory values matter?[J]. J Trauma Acute Care Surg, 2014, 76(1): 121-125. DOI: 10.1097/TA.0b013e3182a9cc95.
|
| [33] |
Jha RM, Zusman BE, Puccio AM, et al. Genetic variants associated with intraparenchymal hemorrhage progression after traumatic brain injury[J]. JAMA Netw Open, 2021, 4(7): e2116839. DOI: 10.1001/jamanetworkopen.2021.16839.
|
| [34] |
Esnault P, Mathais Q, D'Aranda E, et al. Ability of fibrin monomers to predict progressive hemorrhagic injury in patients with severe traumatic brain injury[J]. Neurocrit Care, 2020, 33(1): 182-195. DOI: 10.1007/s12028-019-00882-6.
|
| [35] |
Tréguier Y, Bull-Maurer A, Roingeard P. Apolipoprotein E, a crucial cellular protein in the lifecycle of hepatitis viruses[J]. Int J Mol Sci, 2022, 23(7): 3676. DOI: 10.3390/ijms23073676.
|
| [36] |
Hellstrøm T, Andelic N, Holthe Ø, et al. APOE-ε4 is associated with reduced verbal memory performance and higher emotional, cognitive, and everyday executive function symptoms two months after mild traumatic brain injury[J]. Front Neurol, 2022, 13: 735206. DOI: 10.3389/fneur.2022.735206.
|
| [37] |
Yousefvand S, Hadjzadeh MA, Keshavarzi Z, et al. Effects of prolactin on movement disorders and APOE, GFAP, and PRL receptor gene expression following intracerebral hemorrhage in rats[J]. Iran J Basic Med Sci, 2021, 24(12): 1709-1716. DOI: 10.22038/IJBMS.2021.58176.12927.
|
| [38] |
Wan X, Gan C, You C, et al. Association of APOE ε4 with progressive hemorrhagic injury in patients with traumatic intracerebral hemorrhage[J]. J Neurosurg, 2019, Online ahead of print.
|
| [39] |
Tzioras M, Davies C, Newman A, et al. Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease[J]. Neuropathol Appl Neurobiol, 2019, 45(4): 327-346. DOI: 10.1111/nan.12529.
|
| [40] |
Stanczykiewicz B, Gburek J, Rutkowska M, et al. Ovocystatin induced changes in expression of Alzheimer's disease relevant proteins in APP/PS1 transgenic mice[J]. J Clin Med, 2022, 11(9): 2372. DOI: 10.3390/jcm11092372.
|
| [41] |
Huang HZ, Qiu M, Lin JZ, et al. Potential effect of tropical fruits Phyllanthus emblica L. for the prevention and management of type 2 diabetic complications: a systematic review of recent advances[J]. Eur J Nutr, 2021, 60(7): 3525-3542. DOI: 10.1007/s00394-020-02471-2.
|
| [42] |
Karri J, Cardenas JC, Matijevic N, et al. Early fibrinolysis associated with hemorrhagic progression following traumatic brain injury[J]. Shock, 2017, 48(6): 644-650. DOI: 10.1097/SHK.0000000000000912.
|
| [43] |
Allard CB, Scarpelini S, Rhind SG, et al. Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage[J]. J Trauma, 2009, 67(5): 959-967. DOI: 10.1097/TA.0b013e3181ad5d37.
|
| [44] |
Wu X, Du Z, Yu J, et al. Activity of factor VII in patients with isolated blunt traumatic brain injury: association with coagulopathy and progressive hemorrhagic injury[J]. J Trauma Acute Care Surg, 2014, 76(1): 114-120. DOI: 10.1097/TA.0b013e3182a8fe48.
|
| [45] |
Chen T, Chen S, Wu Y, et al. A predictive model for postoperative progressive haemorrhagic injury in traumatic brain injuries[J]. BMC Neurol, 2022, 22(1): 16. DOI: 10.1186/s12883-021-02541-w.
|
| [46] |
Thurman DJ. The epidemiology of traumatic brain injury in children and youths: a review of research since 1990[J]. J Child Neurol, 2016, 31(1): 20-27. DOI: 10.1177/0883073814544363.
|
| [47] |
Hu GW, Lang HL, Guo H, et al. A risk score based on admission characteristics to predict progressive hemorrhagic injury from traumatic brain injury in children[J]. Eur J Pediatr, 2017, 176(6): 689-696. DOI: 10.1007/s00431-017-2897-9.
|
| [48] |
Yamashita Y, Uozumi R, Hamatani Y, et al. Current status and outcomes of direct oral anticoagulant use in real-world atrial fibrillation patients-Fushimi AF Registry[J]. Circ J, 2017, 81(9): 1278-1285. DOI: 10.1253/circj.CJ-16-1337.
|
| [49] |
Koyama H, Yagi K, Hara K, et al. Combination therapy using prothrombin complex concentrate and vitamin K in anticoagulated patients with traumatic intracranial hemorrhage prevents progressive hemorrhagic injury: a historically controlled study[J]. Neurol Med Chir (Tokyo), 2021, 61(1): 47-54. DOI: 10.2176/nmc.oa.2020-0252.
|
| [50] |
Steiner T, Poli S, Griebe M, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial[J]. Lancet Neurol, 2016, 15(6): 566-573. DOI: 10.1016/S1474-4422(16)00110-1.
|
| [51] |
Jehan F, Aziz H, OʼKeeffe T, et al. The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: a propensity matched analysis[J]. J Trauma Acute Care Surg, 2018, 85(1): 18-24. DOI: 10.1097/TA.0000000000001938.
|
| [52] |
Munlemvo DM, Tobias JD, Chenault KM, et al. Prothrombin complex concentrates to treat coagulation disturbances: an overview with a focus on use in infants and children[J]. Cardiol Res, 2022, 13(1): 18-26. DOI: 10.14740/cr1342.
|
| [53] |
Zeeshan M, Hamidi M, Kulvatunyou N, et al. 3-factor versus 4-factor PCC in coagulopathy of trauma: four is better than three[J]. Shock, 2019, 52(1): 23-28. DOI: 10.1097/SHK.0000000000001240.
|